Abstract Submission Windows

Find the latest information on ASGCT's current and future abstract submission opportunities.

2024 Abstract Submission Opportunities

Advancing Gene and Cell Therapies for Cancer
Oct. 16-17, 2024 | Philadelphia + Virtually

Important Dates

• Abstract Submission Opens: May 1, 2024
• Abstract Submission Closes: July 12, 2024
• Notifications Sent to Authors: August 19, 2024
• Abstracts Released to Public: September 30 @ 4:30 p.m. ET

Submit an Abstract

Breakthroughs in Muscular Dystrophy
Nov. 19-20, 2024 | Chicago, IL + Virtually

Important Dates

• Abstract Submission Opens: May 1, 2024
• Abstract Submission Closes: August 9, 2024
• Notifications Sent to Authors: September 9, 2024
• Abstracts Released to Public: November 4 @ 4:30 p.m. ET

Submit an Abstract

28th Annual Meeting
May 13-17, 2025 | New Orleans, LA

More information coming soon!

ASGCT collects abstracts for our Annual Meetings and hybrid events. Please peruse the boxes below to learn more about the abstract process. Specifics for each event will be listed on the event page.

Whenever an ASGCT event includes abstract presentations, those events will include oral presentations, poster presentations, and ePoster uploads unless otherwise noted.

The ASGCT Annual Meeting also accepts late-breaking abstracts.

Starting in 2024, ASGCT requires all authors to add ORCiD numbers to their profiles. ORCID provides a persistent digital identifier (an ORCID iD) that you own and control and that distinguishes you from every other researcher. Please visit https://orcid.org/ to register and create your ID for free today.

Questions on abstract policies should be emailed to abstracts@asgct.org.